17.70USD+3.45%Mkt Cap: 502.12M USDP/E: —Last update: 2026-05-26
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap502.12M USD
Enterprise Value221.81M USD
Revenue (TTM)320.35M USD
Gross Profit130.88M USD
Net Income (TTM)-60.51M USD
Revenue/Share10.40 USD
Last Price17.70 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS3596641098
Valuation
P/E (Trailing)—
P/E (Forward)-11.38
PEG—
EV/EBITDA-2.87
EV/Revenue0.69
P/S1.54
P/B0.48
EPS (TTM)-2.40
EPS (Forward)-1.53
52W Range
13.4624% of range31.04
52W High31.04 USD
52W Low13.46 USD
Profitability
Gross Margin40.56%
Oper. Margin-45.01%
EBITDA Margin-24.10%
Profit Margin-18.75%
ROE-5.44%
ROA-4.99%
Growth
Revenue Growth-3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-101.64M USD
CapEx (TTM)22.57M USD
FCF Margin-33.07%
FCF Yield-21.10%
Net Debt-266.13M USD
Net Debt/EBITDA3.45
Balance Sheet
Debt/Equity0.01
Current Ratio5.32
Quick Ratio3.91
Book Value/Sh36.39 USD
Cash/Share9.729 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)18.50 USD
Target Range15.00 USD – 22.00 USD
# Analysts2
Ownership
Shares Out.28.40M
Float17.73M
Insiders36.70%
Institutions63.59%
Short Interest
Short Ratio5.7d
Short % Float13.88%
Short % Out.8.81%
Shares Short2.50M
Short (prev mo.)2.47M
Technical
SMA 5015.73 (+12.5%)
SMA 20022.01 (-19.6%)
Beta0.88
S&P 52W Chg28.31%
Avg Vol (30d)527.85K
Avg Vol (10d)510.46K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—